Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Study will investigate tumor stem cells as therapeutic target
February 3rd, 2005
Vera S. Donnenberg, PhD, a scientist with the University of Pittsburgh, has been awarded $3.6 million by the U.S. Department of Defense Breast Cancer Research Program (BCRP) for a project on a new and potentially important target for successful breast cancer therapy: the tumor stem cell. Scientists know that normal stem cells have two critical features: the ability to self-renew and the ability to resist toxins through transporters that pump away foreign substances. According to Donnenberg, this very knowledge may provide a promising new paradigm to understanding the growth and spread of cancer. The project will examine a subset of highly malignant...
Source: Women's Health Weekly (2005-02-03)
|
